10/12/2017
https://www.congress.gov...
"I think it is not sufficient for us to rely on self-reporting anymore."
"Wow."
"For some medications with serious safety concerns, FDA requires manufacturers to set up risk evaluation and mitigation strategies, otherwise known as REMS programs."
"And it is using the notion of patient safety to delay the development of additional drugs that could bring down the cost."